A detailed history of Neuberger Berman Group LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 4,137,246 shares of LAB stock, worth $7.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,137,246
Previous 4,744,923 12.81%
Holding current value
$7.94 Million
Previous $12.9 Million 43.05%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.65 - $2.92 $1 Million - $1.77 Million
-607,677 Reduced 12.81%
4,137,246 $7.32 Million
Q1 2024

May 13, 2024

BUY
$1.87 - $2.78 $8.87 Million - $13.2 Million
4,744,923 New
4,744,923 $12.9 Million
Q4 2023

Feb 09, 2024

SELL
$1.59 - $2.73 $282,851 - $485,650
-177,894 Reduced 3.92%
4,365,813 $9.65 Million
Q3 2023

Nov 14, 2023

BUY
$1.9 - $3.05 $73,260 - $117,601
38,558 Added 0.86%
4,543,707 $13.2 Million
Q2 2023

Aug 11, 2023

SELL
$1.47 - $2.56 $5,331 - $9,285
-3,627 Reduced 0.08%
4,505,149 $8.69 Million
Q1 2023

May 12, 2023

BUY
$1.3 - $2.24 $202,989 - $349,767
156,146 Added 3.59%
4,508,776 $8.79 Million
Q4 2022

Feb 13, 2023

SELL
$0.93 - $1.52 $10,567 - $17,271
-11,363 Reduced 0.26%
4,352,630 $5.09 Million
Q3 2022

Nov 15, 2022

BUY
$1.1 - $2.06 $436,618 - $817,667
396,926 Added 10.01%
4,363,993 $4.81 Million
Q2 2022

Aug 15, 2022

BUY
$1.6 - $3.99 $24,115 - $60,137
15,072 Added 0.38%
3,967,067 $6.35 Million
Q1 2022

May 13, 2022

SELL
$2.8 - $3.96 $682,337 - $965,020
-243,692 Reduced 5.81%
3,951,995 $14 Million
Q4 2021

Feb 11, 2022

SELL
$3.63 - $6.13 $306,745 - $518,003
-84,503 Reduced 1.97%
4,195,687 $16.2 Million
Q3 2021

Nov 12, 2021

SELL
$5.5 - $7.41 $348,188 - $469,104
-63,307 Reduced 1.46%
4,280,190 $27.7 Million
Q2 2021

Aug 13, 2021

SELL
$4.35 - $6.35 $163,908 - $239,268
-37,680 Reduced 0.86%
4,343,497 $26.5 Million
Q1 2021

May 13, 2021

SELL
$3.94 - $7.09 $1.04 Million - $1.87 Million
-263,377 Reduced 5.67%
4,381,177 $19.7 Million
Q4 2020

Feb 10, 2021

BUY
$5.45 - $8.65 $1.54 Million - $2.44 Million
281,945 Added 6.46%
4,644,554 $27.8 Million
Q3 2020

Nov 12, 2020

SELL
$4.34 - $11.43 $5.8 Million - $15.3 Million
-1,336,970 Reduced 23.46%
4,362,609 $32.4 Million
Q2 2020

Aug 13, 2020

SELL
$1.85 - $5.29 $208,047 - $594,902
-112,458 Reduced 1.93%
5,699,579 $22.9 Million
Q1 2020

May 14, 2020

BUY
$1.24 - $4.35 $176,943 - $620,727
142,696 Added 2.52%
5,812,037 $14.8 Million
Q4 2019

Feb 12, 2020

BUY
$2.3 - $5.12 $610,546 - $1.36 Million
265,455 Added 4.91%
5,669,341 $19.7 Million
Q3 2019

Nov 13, 2019

BUY
$4.63 - $12.15 $1.39 Million - $3.65 Million
300,763 Added 5.89%
5,403,886 $25 Million
Q2 2019

Aug 13, 2019

SELL
$11.49 - $14.17 $1.28 Million - $1.58 Million
-111,431 Reduced 2.14%
5,103,123 $62.9 Million
Q1 2019

May 13, 2019

SELL
$8.47 - $14.36 $2.12 Million - $3.6 Million
-250,420 Reduced 4.58%
5,214,554 $69.3 Million
Q4 2018

Feb 12, 2019

BUY
$7.18 - $8.83 $6.68 Million - $8.21 Million
929,794 Added 20.5%
5,464,974 $47.1 Million
Q3 2018

Nov 13, 2018

BUY
$5.92 - $8.35 $143,181 - $201,953
24,186 Added 0.54%
4,535,180 $34 Million
Q2 2018

Aug 13, 2018

SELL
$4.86 - $6.24 $51,457 - $66,069
-10,588 Reduced 0.23%
4,510,994 $26.9 Million
Q1 2018

May 08, 2018

SELL
$5.75 - $7.97 $1.29 Million - $1.78 Million
-223,774 Reduced 4.72%
4,521,582 $26.4 Million
Q4 2017

Feb 14, 2018

SELL
$4.46 - $6.45 $2.09 Million - $3.02 Million
-468,125 Reduced 8.98%
4,745,356 $28 Million
Q3 2017

Nov 15, 2017

BUY
$3.55 - $5.49 $18.5 Million - $28.6 Million
5,213,481
5,213,481 $26.3 Million

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $151M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.